SCHEMBL4931364

SCHEMBL4931364

CNc1cc(COc2c(Cl)cc(NC(=O)CC(=O)O)cc2Cl)cc(C(F)(F)F)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.44
ALDH1A1 P00352 3/20 0.43
MRGPRX4 Q96LA9 3/20 0.41
TACR1 P25103 1/20 0.40
KDR P35968 3/20 0.40
MAPK14 Q16539 3/20 0.40
TNNI3K Q59H18 3/20 0.40
SLC13A3 Q8WWT9 1/20 0.39
MAPT P10636 1/20 0.39
ACP1 P24666 1/20 0.38
RHOC P08134 1/20 0.38
RHOA P61586 1/20 0.38
THRA P10827 1/20 0.38
THRB P10828 1/20 0.38
P2RX1 P51575 1/20 0.37
P2RX4 Q99571 1/20 0.37
P2RX7 Q99572 1/20 0.37
TMPRSS4 Q9NRS4 1/20 0.37
RORA P35398 1/20 0.37
NR2E1 Q9Y466 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5111277 0.91 ALDH1A1 (0.46) LMNAALDH1A1MRGPRX4TACR1KDR
SCHEMBL5119858 0.91 LMNA (0.44) LMNAALDH1A1MRGPRX4TACR1SLC13A3
SCHEMBL4935433 0.89 TRPA1 (0.43) LMNAALDH1A1MRGPRX4TACR1KDR
SCHEMBL4934596 0.89 THRA (0.47) LMNAALDH1A1MRGPRX4TACR1SLC13A3
SCHEMBL4931997 0.89 ALDH1A1 (0.46) LMNAALDH1A1MRGPRX4TACR1ACP1
SCHEMBL5110736 0.89 ALDH1A1 (0.46) LMNAALDH1A1MRGPRX4TACR1ACP1
SCHEMBL4931483 0.89 TRPA1 (0.47) LMNAALDH1A1MRGPRX4TACR1MAPT
SCHEMBL4931227 0.88 LMNA (0.45) LMNAALDH1A1MRGPRX4TACR1KDR
SCHEMBL5718251 0.87 THRB (0.39) LMNAALDH1A1MRGPRX4THRATHRB
SCHEMBL5722504 0.87 THRA (0.43) LMNAALDH1A1MRGPRX4TACR1ACP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221210-A1 Thyroid Receptor Agonists KARO BIO AB (SE) 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221210-A1 Thyroid Receptor Agonists TSHR, TRHR, THRA LMNA 3893/4885ALDH1A1 1818/4885MRGPRX4 119/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.